Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8523052rdf:typepubmed:Citationlld:pubmed
pubmed-article:8523052lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8523052lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:8523052lifeskim:mentionsumls-concept:C0151779lld:lifeskim
pubmed-article:8523052lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:8523052lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:8523052lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:8523052pubmed:issue12lld:pubmed
pubmed-article:8523052pubmed:dateCreated1996-1-19lld:pubmed
pubmed-article:8523052pubmed:abstractTextA phase II study was undertaken to determine the efficacy of docetaxel in patients with metastatic malignant melanoma.lld:pubmed
pubmed-article:8523052pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8523052pubmed:languageenglld:pubmed
pubmed-article:8523052pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8523052pubmed:citationSubsetIMlld:pubmed
pubmed-article:8523052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8523052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8523052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8523052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8523052pubmed:statusMEDLINElld:pubmed
pubmed-article:8523052pubmed:monthDeclld:pubmed
pubmed-article:8523052pubmed:issn0732-183Xlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:Von HoffD DDDlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:JenkinsJJlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:LeghaS SSSlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:BedikianA YAYlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:BuzaidA CAClld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:BurrisH...lld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:WeissG RGRlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:EckardtJ RJRlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:EtonOOlld:pubmed
pubmed-article:8523052pubmed:authorpubmed-author:SmetzerLLlld:pubmed
pubmed-article:8523052pubmed:issnTypePrintlld:pubmed
pubmed-article:8523052pubmed:volume13lld:pubmed
pubmed-article:8523052pubmed:ownerNLMlld:pubmed
pubmed-article:8523052pubmed:authorsCompleteNlld:pubmed
pubmed-article:8523052pubmed:pagination2895-9lld:pubmed
pubmed-article:8523052pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:meshHeadingpubmed-meshheading:8523052-...lld:pubmed
pubmed-article:8523052pubmed:year1995lld:pubmed
pubmed-article:8523052pubmed:articleTitlePhase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.lld:pubmed
pubmed-article:8523052pubmed:affiliationDepartment of Melanoma/Sarcoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.lld:pubmed
pubmed-article:8523052pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8523052pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8523052pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8523052lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8523052lld:pubmed